Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve 2/2025-26 Meeting ....
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Syncom Formulations India has informed the stock exchanges that its Board of Directors will meet on 8th August 2025 at 4:00 PM at the corporate office in Indore. The main agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June 2025 (Q1 FY26). The board will also take on record the Limited Review Report by the auditors for these results. The filing is made under SEBI LODR Regulation 29(1)(a) and is a standard procedural intimation. The trading window closure details have already been updated with the designated depository.
This is a routine pre-results announcement with no financial figures disclosed yet. Investors should wait for the actual Q1 FY26 results on or after 8th August 2025 to assess the company's performance. No immediate impact on stock price is expected from this filing alone.